Plan Your Winter Vacay to Do Good in the World

A Weekend Getaway with a Purpose

Sign Up Now for The Leukemia & Lymphoma Society's Team In Training

The days are getting longer and hotter but it's not too soon to make this winter's vacation a life saver. For the experience of a lifetime you can spend the next four to five months preparing for a full or half marathon or century ride at a fabulous destination all while raising money to help fund blood cancer research.

The Leukemia & Lymphoma Society's (LLS) Team In Training® program (TNT) is signing up runners, walkers and cyclists for events at winter destinations including magical Walt Disney World in Orlando, Fla., quaint scenic St. Petersburg, Fla., exotic Honolulu, HI and enchanting San Antonio, TX. Consider combining a fun vacation at a warm winter spot with the opportunity to accomplish an incredible feat and support lifesaving research.

TNT, the world's first, biggest and best sports training and fundraising program, provides participants with a four-to-five month comprehensive training program, certified coaches and travel and accommodations at the venue of their choice. In return, participants help in the fight against leukemia, lymphoma and myeloma by raising funds to support blood cancer research, education and services for patients and their families.

"Taking vacations that include a component for helping others in need is a growing trend," said Donna Grogan, Vice President, Sports Training Programs for LLS. "TNT provides participants a great opportunity to travel to a great destination while also giving them the satisfaction of knowing they are making a difference in the lives of blood cancer patients."

To sign up visit www.teamintraining.org

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap